Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
tablet
injection ophthalmic solution |
| gptkbp:brand |
gptkb:Toradol
Acular |
| gptkbp:chemicalFormula |
C15H13NO3
|
| gptkbp:clinicalTrials |
migraine treatment
menstrual pain cancer pain acute pain management musculoskeletal pain dental pain pain from trauma postoperative pain renal colic biliary_colic |
| gptkbp:contraindication |
peptic ulcer disease
active bleeding severe renal impairment |
| gptkbp:developedBy |
gptkb:Roche
|
| gptkbp:dosageForm |
oral tablet
eye drops injection solution |
| gptkbp:duration |
6 to 8 hours
|
| gptkbp:endOfLife |
5 to 6 hours
|
| gptkbp:gestationPeriod |
C
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ketorolac
|
| gptkbp:inheritsFrom |
30 minutes to 1 hour
|
| gptkbp:interactsWith |
alcohol
anticoagulants other NSAIDs |
| gptkbp:isRecognizedFor |
pregnant women
nursing mothers children under 2 years |
| gptkbp:lastProduced |
1989
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:route |
oral
intravenous intramuscular |
| gptkbp:sideEffect |
dizziness
headache nausea gastrointestinal bleeding |
| gptkbp:triggerType |
inhibition_of_cyclooxygenase_(COX)_enzymes
|
| gptkbp:usedFor |
pain relief
|
| gptkbp:waterManagement |
urine
|
| gptkbp:weight |
255.27 g/mol
|